Big Pharma Stock Forward View - Accumulation Distribution
| PRM Stock | CAD 14.05 0.29 2.11% |
This page provides Accumulation Distribution reference data for Big Pharma Split, calculated from historical daily prices. The model output shown here is derived from Big Pharma's historical price series and is provided for informational purposes.
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume The Accumulation Distribution reference information for Big Pharma is based on available price data and is intended for informational purposes. Accumulation Distribution Analysis Today
Big Pharma Split has current Accumulation Distribution of 114.16. The accumulation distribution (A/D) indicator shows the degree to which Big Pharma is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Big Pharma Split to determine if accumulation or reduction is taking place in the market. This value is adjusted by Big Pharma trading volume to give more weight to distributions with higher volume over lower volume.| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 42.58 | 114.16 |
| Volatility | Backtest | Information Ratio |
Big Pharma Trading Date Momentum
| On March 25 2026 Big Pharma Split was traded for 14.05 at the closing time. The maximum traded price for the trading interval was 14.49 and the lowest daily price was 13.57 . The daily volume was recorded at 1.8 K. The volume of trading on 25th of March 2026 did not affect price variability. The overall trading delta to the closing price today is 3.13% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Big Pharma to competition |
Other Forecasting Options for Big Pharma
The autocorrelation structure of Big Pharma's daily returns reveals whether Big exhibits momentum, mean-reversion, or random-walk behavior. Separating these elements helps distinguish persistent directional moves from temporary noise in Big Stock price data.Big Pharma Related Equities
Big Pharma's market space within the Financials space is best grasped by looking at the firms listed below. Growth rate gaps between Big Pharma and its peers often explain pricing differences in the market. Firms that trade at big discounts to peers on core metrics may be worth more research.
| Risk & Return | Correlation |
Big Pharma Market Strength Events
Market strength indicators applied to Big Pharma stock help assess momentum and resilience across environments. These indicators support informed market timing decisions when analyzing Big Pharma.
Big Pharma Risk Indicators
Risk indicator analysis for Big Pharma is essential for accurately projecting its future price trajectory. The process involves identifying the amount of risk involved in Big Pharma's investment and either accepting or mitigating it.
| Mean Deviation | 1.16 | |||
| Semi Deviation | 1.34 | |||
| Standard Deviation | 1.63 | |||
| Variance | 2.64 | |||
| Downside Variance | 3.32 | |||
| Semi Variance | 1.79 | |||
| Expected Short fall | -1.40 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Big Pharma
The amount of media and story coverage tied to Big Pharma Split can signal where market attention is concentrating at the moment. Used properly, this context can help investors judge whether visibility is reinforcing the thesis or attracting more speculative pressure.
Other Macroaxis Stories
Macroaxis story coverage is designed for a broad investing audience that ranges from self-directed traders to advisers, researchers, and institutional market participants. The content is intended to support people who want a more structured path from headline information to portfolio action.
Story Categories
Currently Trending Categories
Big Pharma Short Properties
Short-interest signals around Big Pharma Split can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. A disciplined short-interest review can make timing decisions more informed under rising skepticism.
| Common Stock Shares Outstanding | 1.1 M | |
| Cash And Short Term Investments | 26.2 M |
More Resources for Big Stock Analysis
Other Information on Investing in Big Stock
Financial ratios for Big Pharma show relationships between important financial metrics. The format ensures financial data remains comparable across time periods.